JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area epigenetics parp'

Search results for: 'research area epigenetics parp'

A4114 MLN8054

Target: Aurora Kinases

Summary: Aurora A inhibitor

insoluble in EtOH; insoluble in H2O; ≥39.05 mg/mL
A4121 SNS-314 Mesylate

Target: Aurora Kinases

Summary: Aurora A/B/C kinases inhibitor, potent and selective

≥26.35 mg/mL
A1907 5-Azacytidine

6 Citation

Target: DNA Methyltransferases

Summary: DNA methyltransferase inhibitor.

insoluble in EtOH; ≥24.45 mg/mL
A1912 Lomeguatrib

Target: O6-methylguanine-DNA-methyl-transferase (MGMT)

Summary: MGMT inhibitor

≥50 mg/mL
A1915 Zebularine

1 Citation

Target: DNA Methyltransferases|Cytidine deaminases

Summary: DNA methylation inhibitor

insoluble in EtOH; ≥50.7 mg/mL
A3214 AZD1152

1 Citation

Target: Aurora Kinases

Summary: Aurora B kinase inhibitor,highly potent and selective

insoluble in H2O; insoluble in EtOH; ≥5.88 mg/mL
A8547 Tubastatin A HCl

1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor,potent and selective

insoluble in EtOH; ≥12.34 mg/mL
A8178 Panobinostat (LBH589)

10 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL
A4090 JNJ-26481585

3 Citation

Target: Histone Deacetylases (HDACs)

Summary: Potent HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥19.2 mg/mL
A4111 VX-680 (MK-0457,Tozasertib)

Target: Aurora Kinases

Summary: Aurora kinase inhibitor

≥23.25 mg/mL